Geopolitics Alpha

Aytu Biopharma (AYTU): filings, insider buys & geopolitical news

In the last 30 days, Geopolitics Alpha logged 2 items on Aytu Biopharma: 0 news stories, 2 SEC filings and 0 fund or insider trade reports. The latest filing was logged 16 Nov 2026: 8-K - AYTU BIOPHARMA, INC (0001385818) (Filer).

Government contracts

No federal prime contract obligations are matched to Aytu Biopharma in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.

AYTU share price, last 12 months

Close $2.05 on Oct 5, 2026, -0.5% since Nov 13, 2025 (range $1.94 to $2.90, daily closes).

What changed for Aytu Biopharma (AYTU)

In the last 30 days, Geopolitics Alpha logged 2 items on Aytu Biopharma: 0 news stories, 2 SEC filings and 0 fund or insider trade reports. The latest filing was logged 16 Nov 2026: 8-K - AYTU BIOPHARMA, INC (0001385818) (Filer).

Latest SEC filings

Latest fund & insider buys and sales

None on record yet.

Latest geopolitical & market news

None on record yet.

Congressional trades in AYTU

Trades in AYTU that members of Congress have publicly reported, newest filing first.

No congressional trades are stored for this view yet.

All congressional stock trades →

Geopolitical news for AYTU

Everything on AYTU, newest first

Frequently asked questions

Does Aytu Biopharma have government contracts?

No federal prime contract obligations are matched to Aytu Biopharma (AYTU) in USAspending.gov for the last five years. Subcontracts are not included.

Where does the contract data come from?

USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.

What geopolitical news affects AYTU?

This page lists every Geopolitics Alpha note that names AYTU as exposed to an event, with the reason it is exposed.

Has Congress traded AYTU?

The table above lists trades in AYTU that members of Congress have publicly reported, with a link to each official filing.

Is this investment advice?

No. We show news, exposure and past price moves. Nothing here is a recommendation.